Ding‐Wu Shen

2.6k total citations · 1 hit paper
24 papers, 2.1k citations indexed

About

Ding‐Wu Shen is a scholar working on Oncology, Molecular Biology and Cell Biology. According to data from OpenAlex, Ding‐Wu Shen has authored 24 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Molecular Biology and 10 papers in Cell Biology. Recurrent topics in Ding‐Wu Shen's work include Drug Transport and Resistance Mechanisms (12 papers), Microtubule and mitosis dynamics (8 papers) and DNA Repair Mechanisms (7 papers). Ding‐Wu Shen is often cited by papers focused on Drug Transport and Resistance Mechanisms (12 papers), Microtubule and mitosis dynamics (8 papers) and DNA Repair Mechanisms (7 papers). Ding‐Wu Shen collaborates with scholars based in United States, China and Malaysia. Ding‐Wu Shen's co-authors include Michael M. Gottesman, Matthew D. Hall, Lynn M. Pouliot, Xing‐Jie Liang, Mitsunori Okabe, Ira Pastan, Jun‐Jie Yin, Susan H. Garfield, Antonio Tito Fojo and Sarah Goldenberg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

Ding‐Wu Shen

24 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cisplatin Resistance: A Cellular Self-Defense Mechanism Resulting from Multiple Epigenetic and Genetic Changes

2012 751 citations Ding‐Wu Shen, Lynn M. Pouliot et al. Pharmacological Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ding‐Wu Shen United States	18	1.1k	999	313	287	238	24	2.1k
M. Eileen Dolan United States	18	1.3k 1.2×	850 0.9×	304 1.0×	291 1.0×	143 0.6×	27	2.4k
Christine Pirker Austria	31	1.4k 1.3×	1.0k 1.0×	423 1.4×	448 1.6×	125 0.5×	92	3.0k
Angelica M. Merlot Australia	21	1.0k 0.9×	631 0.6×	255 0.8×	185 0.6×	126 0.5×	24	2.2k
Franco Zunino Italy	30	1.5k 1.3×	1.5k 1.5×	705 2.3×	263 0.9×	168 0.7×	73	3.1k
Ida Landini Italy	28	1.1k 1.0×	1.6k 1.6×	877 2.8×	321 1.1×	224 0.9×	49	2.9k
Jürgen Thomale Germany	29	1.7k 1.5×	765 0.8×	211 0.7×	558 1.9×	306 1.3×	76	2.8k
John J. Pink United States	28	1.8k 1.6×	820 0.8×	666 2.1×	287 1.0×	143 0.6×	60	3.2k
Valentina De Falco Italy	25	1.3k 1.1×	892 0.9×	185 0.6×	274 1.0×	119 0.5×	40	2.6k
Hyo Jin Kang South Korea	32	1.7k 1.5×	476 0.5×	215 0.7×	360 1.3×	237 1.0×	103	2.9k
Nouri Neamati United States	26	1.1k 1.0×	923 0.9×	635 2.0×	174 0.6×	99 0.4×	50	2.5k

Countries citing papers authored by Ding‐Wu Shen

Since Specialization

Citations

This map shows the geographic impact of Ding‐Wu Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ding‐Wu Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ding‐Wu Shen more than expected).

Fields of papers citing papers by Ding‐Wu Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ding‐Wu Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ding‐Wu Shen. The network helps show where Ding‐Wu Shen may publish in the future.

Co-authorship network of co-authors of Ding‐Wu Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Ding‐Wu Shen. A scholar is included among the top collaborators of Ding‐Wu Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ding‐Wu Shen. Ding‐Wu Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shen, Ding‐Wu, Lynn M. Pouliot, Matthew D. Hall, & Michael M. Gottesman. (2012). Cisplatin Resistance: A Cellular Self-Defense Mechanism Resulting from Multiple Epigenetic and Genetic Changes. Pharmacological Reviews. 64(3). 706–721. 751 indexed citations breakdown →

Shen, Ding‐Wu, Lynn M. Pouliot, Jean‐Pierre Gillet, et al.. (2012). The Transcription Factor GCF2 Is an Upstream Repressor of the Small GTPAse RhoA, Regulating Membrane Protein Trafficking, Sensitivity to Doxorubicin, and Resistance to Cisplatin. Molecular Pharmaceutics. 9(6). 1822–1833. 20 indexed citations

Pouliot, Lynn M., Ding‐Wu Shen, Toshihiro Suzuki, Matthew D. Hall, & Michael M. Gottesman. (2012). Contributions of microRNA dysregulation to cisplatin resistance in adenocarcinoma cells. Experimental Cell Research. 319(4). 566–574. 21 indexed citations

Shen, Ding‐Wu & Michael M. Gottesman. (2011). RAB8 Enhances TMEM205-Mediated Cisplatin Resistance. Pharmaceutical Research. 29(3). 643–650. 27 indexed citations

Shen, Ding‐Wu, Jichun Ma, Mitsunori Okabe, et al.. (2010). Elevated expression of TMEM205, a hypothetical membrane protein, is associated with cisplatin resistance. Journal of Cellular Physiology. 225(3). 822–828. 36 indexed citations

Liang, Xing‐Jie, Huan Meng, Yingze Wang, et al.. (2010). Metallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis. Proceedings of the National Academy of Sciences. 107(16). 7449–7454. 207 indexed citations

Liang, Xing‐Jie, Jun‐Jie Yin, Barbara J. Taylor, et al.. (2008). Disruption of microfilaments by cytochalasin B decreases accumulation of cisplatin in human epidermal carcinoma and liver carcinoma cell lines. Cancer Chemotherapy and Pharmacology. 62(6). 977–984. 7 indexed citations

Liang, Xing‐Jie, Toren Finkel, Ding‐Wu Shen, et al.. (2008). SIRT1 Contributes in Part to Cisplatin Resistance in Cancer Cells by Altering Mitochondrial Metabolism. Molecular Cancer Research. 6(9). 1499–1506. 100 indexed citations

Shen, Ding‐Wu, Xing‐Jie Liang, Toshihiro Suzuki, & Michael M. Gottesman. (2006). Identification by Functional Cloning from a Retroviral cDNA Library of cDNAs for Ribosomal Protein L36 and the 10-kDa Heat Shock Protein that Confer Cisplatin Resistance. Molecular Pharmacology. 69(4). 1383–1388. 28 indexed citations

10.

Liang, Xing‐Jie, Sushmita Mukherjee, Ding‐Wu Shen, Frederick R. Maxfield, & Michael M. Gottesman. (2006). Endocytic Recycling Compartments Altered in Cisplatin-Resistant Cancer Cells. Cancer Research. 66(4). 2346–2353. 49 indexed citations

11.

Liang, Xing‐Jie, Ding‐Wu Shen, Stephen Wincovitch, Susan H. Garfield, & Michael M. Gottesman. (2004). Localization of Alexa-conjugated cisplatin in cisplatin-resistant cell lines. Cancer Research. 64. 279–279. 1 indexed citations

12.

Liang, Xing‐Jie, Ding‐Wu Shen, & Michael M. Gottesman. (2004). A pleiotropic defect reducing drug accumulation in cisplatin-resistant cells. Journal of Inorganic Biochemistry. 98(10). 1599–1606. 20 indexed citations

13.

Liang, Xing‐Jie, Ding‐Wu Shen, & Michael M. Gottesman. (2004). Down-Regulation and Altered Localization of γ-Catenin in Cisplatin-Resistant Adenocarcinoma Cells. Molecular Pharmacology. 65(5). 1217–1224. 15 indexed citations

14.

Liang, Xing‐Jie, Ding‐Wu Shen, Kevin G. Chen, et al.. (2004). Trafficking and localization of platinum complexes in cisplatin‐resistant cell lines monitored by fluorescence‐labeled platinum. Journal of Cellular Physiology. 202(3). 635–641. 52 indexed citations

15.

Shen, Ding‐Wu, et al.. (2003). Codominance of cisplatin resistance in somatic cell hybrids. Journal of Cellular Physiology. 196(1). 63–69. 3 indexed citations

16.

Liang, Xing‐Jie, Ding‐Wu Shen, Susan H. Garfield, & Michael M. Gottesman. (2003). Mislocalization of membrane proteins associated with multidrug resistance in cisplatin-resistant cancer cell lines.. PubMed. 63(18). 5909–16. 83 indexed citations

17.

Shen, Ding‐Wu, Sarah Goldenberg, Ira Pastan, & Michael M. Gottesman. (2000). Decreased accumulation of [14c]carboplatin in human cisplatin-resistant cells results from reduced energy-dependent uptake. Journal of Cellular Physiology. 183(1). 108–116. 77 indexed citations

18.

Shen, Ding‐Wu, Sarah Goldenberg, Ira Pastan, & Michael M. Gottesman. (2000). Decreased accumulation of [14c]carboplatin in human cisplatin-resistant cells results from reduced energy-dependent uptakeThis article is a US Government work and, as such, is in the public domain in the United States of America.. Journal of Cellular Physiology. 183(1). 108–108. 3 indexed citations

19.

Fojo, Antonio Tito, Marilyn M. Cornwell, Carol Cardarelli, et al.. (1987). Molecular biology of drug resistance. Breast Cancer Research and Treatment. 9(1). 5–16. 23 indexed citations

20.

Shen, Ding‐Wu, Antonio Tito Fojo, Igor B. Roninson, et al.. (1986). Multidrug Resistance of DNA-Mediated Transformants is Linked to Transfer of the Human mdr1 Gene. Molecular and Cellular Biology. 6(11). 4039–4045. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact